|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
2 Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA
3 Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: jeffrey.matthews{at}uc.edu.
Tumor necrosis factor (TNF) increases epithelial permeability in many model systems. Protein kinase C (PKC) isozymes regulate epithelial barrier function and alter ligand-receptor interactions. We sought to define the impact of PKC on TNF-induced barrier dysfunction in T84 intestinal epithelia. TNF induced a dose- and time-dependent fall in transepithelial electrical resistance (TER) and an increase in 3H-mannitol flux. The TNF-induced fall in TER was not PKC-mediated, but was prevented by pre-treatment with bryostatin-1, a PKC agonist. Based on a pattern of sensitivity to pharmacologic inhibitors of PKC, this epithelial barrier preservation was mediated by novel PKC isozymes. Bryostatin-1 reduced TNF receptor (TNF-R1) surface availability, based on radio-labeled TNF binding and cell surface biotinylation assays, and increased TNF-R1 receptor shedding. The pattern of sensitivity to isozyme-selective PKC inhibitors suggested that these effects were mediated by activation of PKC
. In addition, after bryostatin-1 treatment, PKC
and TNF-R1 became associated based on mutual co-immunoprecipitation assay, which has been shown to lead to receptor desensitization in neutrophils. TNF-induced barrier dysfunction occurs independently of PKC, but selective modulation of novel PKC isozymes may regulate TNF-R1 signaling.
This article has been cited by other articles:
![]() |
M. R. Wilson, M. E. Goddard, K. P. O'Dea, S. Choudhury, and M. Takata Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L60 - L68. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L.J. Zhang, M. Shaikh, J.Z. Fields, A. Farhadi, and A. Keshavarzian {theta}-Isoform of PKC is required for alterations in cytoskeletal dynamics and barrier permeability in intestinal epithelium: a novel function for PKC-{theta} Am J Physiol Cell Physiol, July 1, 2004; 287(1): C218 - C234. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, X. Wang, and B. M. Evers Induction of cIAP-2 in Human Colon Cancer Cells through PKC{delta}/NF-{kappa}B J. Biol. Chem., December 19, 2003; 278(51): 51091 - 51099. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |